Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt

作     者：Haoyu Wang Fuquan Liu Haoyu Wang;Fuquan Liu

作者机构：Peking University the 9th Clinical Medical College Shijitan HospitalBeijing 100038China 

出 版 物：《iLIVER》 (国际肝胆健康（英文）)

年 卷 期：2023年第2卷第1期

页      面：67-72页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Beijing Shijitan Hospital 

主　　题：Hepatopulmonary syndrome Hepatorenal syndrome Transjugular intrahepatic portosystemic shunt 

摘      要：Hepatorenal syndrome(HRS)and hepatopulmonary syndrome(HPS)are two serious complications of liver disease,causing damage not only to the liver but also to the kidneys,lungs,and *** and HPS affect the patient s circulatory and respiratory systems,with poor prognosis and high mortality in clinical *** is a lack of effective treatment other than liver *** intrahepatic portosystemic shunt(TIPS)is an effective tool to prolong the survival of patients with advanced liver disease and is mainly used to treat portal hypertension and ascites because it can effectively reduce portal *** on the treatment of both of these complications with TIPS are limited and deserve further study because the therapeutic effects of TIPS have the potential to improve the prognosis of severe liver *** article reviews the clinical features of HRS and HPS,the consequences of these syndromes,and the potential mechanistic effects after TIPS intervention.